{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:30:34Z","timestamp":1789126234495,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:00:00Z","timestamp":1572307200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:00:00Z","timestamp":1572307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1038\/s41409-019-0730-y","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T20:38:52Z","timestamp":1572467932000},"page":"780-786","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Letermovir prophylaxis through day 100 post transplant is safe and effective compared with alternative CMV prophylaxis strategies following adult cord blood and haploidentical cord blood transplantation"],"prefix":"10.1038","volume":"55","author":[{"given":"Prashant","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neel","family":"Gakhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maheen Z.","family":"Abidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Benamu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valida","family":"Bajrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enkhtsetseg","family":"Purev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0056-6023","authenticated-orcid":false,"given":"Bradley M.","family":"Haverkos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Chase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Gutman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,29]]},"reference":[{"key":"730_CR1","doi-asserted-by":"publisher","first-page":"5689","DOI":"10.1182\/blood-2011-06-361618","volume":"118","author":"F Milano","year":"2011","unstructured":"Milano F, Pergam SA, Xie H, Leisenring WM, Gutman JA, Riffkin I, et al. Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients. Blood. 2011;118:5689\u201396.","journal-title":"Blood"},{"key":"730_CR2","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.3109\/10428194.2014.963079","volume":"56","author":"PB Dahi","year":"2015","unstructured":"Dahi PB, Perales MA, Devlin SM, Olson A, Lubin M, Gonzales AM, et al. Incidence, nature and mortality of cytomegalovirus infection after double-unit cord blood transplant. Leuk Lymphoma. 2015;56:1799\u2013805.","journal-title":"Leuk Lymphoma"},{"key":"730_CR3","first-page":"1290","volume":"90","author":"A Takami","year":"2005","unstructured":"Takami A, Mochizuki K, Asakura H, Yamazaki H, Okumura H, Nakao S. High incidence of cytomegalovirus reactivation in adult recipients of an unrelated cord blood transplant. Haematol-Hematol J. 2005;90:1290\u20132.","journal-title":"Haematol-Hematol J"},{"key":"730_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.bbmt.2009.09.019","volume":"16","author":"JC Beck","year":"2010","unstructured":"Beck JC, Wagner JE, DeFor TE, Brunstein CG, Schleiss MR, Young JA, et al. Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation. Biol Blood Marrow Transplant. 2010;16:215\u201322.","journal-title":"Biol Blood Marrow Transplant"},{"key":"730_CR5","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1016\/j.bbmt.2018.12.182","volume":"25","author":"C Lau","year":"2019","unstructured":"Lau C, Politikos I, Maloy M, Naputo K, Afuye A, Devlin SM, et al. Letermovir prophylaxis demonstrates high efficacy in adult cytomegalovirus (CMV) seropositive cord blood transplant (CBT) recipients: a comparison with pre-letermovir era CBT controls. Biol Blood Marrow Transplant. 2019;25:S94\u201395.","journal-title":"Biol Blood Marrow Transplant"},{"key":"730_CR6","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","volume":"377","author":"FM Marty","year":"2017","unstructured":"Marty FM, Ljungman P, Chemaly RF, Maertens J, Dadwal SS, Duarte RF, et al. Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation. N Engl J Med. 2017;377:2433\u201344.","journal-title":"N Engl J Med"},{"key":"730_CR7","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1182\/blood-2016-10-748426","volume":"129","author":"JA Hill","year":"2017","unstructured":"Hill JA, Mayer BT, Xie H, Leisenring WM, Huang ML, Stevens-Ayers T, et al. The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality. Blood. 2017;129:2316\u201325.","journal-title":"Blood"},{"key":"730_CR8","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/j.bbmt.2016.06.012","volume":"22","author":"K Ballen","year":"2016","unstructured":"Ballen K, Woo Ahn K, Chen M, Abdel-Azim H, Ahmed I, Aljurf M, et al. Infection rates among acute leukemia patients receiving alternative donor hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2016;22:1636\u201345.","journal-title":"Biol Blood Marrow Transplant"},{"key":"730_CR9","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.clim.2008.02.008","volume":"127","author":"JA Brown","year":"2008","unstructured":"Brown JA, Boussiotis VA. Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution. Clin Immunol. 2008;127:286\u201397.","journal-title":"Clin Immunol"},{"key":"730_CR10","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.1182\/blood-2007-05-092130","volume":"110","author":"KV Komanduri","year":"2007","unstructured":"Komanduri KV, St John LS, de Lima M, McMannis J, Rosinski S, McNiece I, et al. Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood. 2007;110:4543\u201351.","journal-title":"Blood"},{"key":"730_CR11","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1182\/blood.V99.8.3050","volume":"99","author":"P Ljungman","year":"2002","unstructured":"Ljungman P, de La Camara R, Milpied N, Volin L, Russell CA, Crisp A, et al. Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants. Blood. 2002;99:3050\u20136.","journal-title":"Blood"},{"key":"730_CR12","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1086\/367836","volume":"36","author":"DJ Winston","year":"2003","unstructured":"Winston DJ, Yeager AM, Chandrasekar PH, Snydman DR, Petersen FB, Territo MC, et al. Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation. Clin Infect Dis. 2003;36:749\u201358.","journal-title":"Clin Infect Dis"},{"key":"730_CR13","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1016\/j.bbmt.2018.05.008","volume":"24","author":"JA Hill","year":"2018","unstructured":"Hill JA, Pergam SA, Cox E, Xie H, Leisenring WM, Boeckh M, et al. A modified intensive strategy to prevent cytomegalovirus disease in seropositive umbilical cord blood transplantation recipients. Biol Blood Marrow Transplant. 2018;24:2094\u20132100.","journal-title":"Biol Blood Marrow Transplant"},{"key":"730_CR14","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1016\/j.bbmt.2018.06.029","volume":"24","author":"BM Knoll","year":"2018","unstructured":"Knoll BM, Peixoto D, Koo S, Hammond SP, Ho VT, Antin JH, et al. Cytomegalovirus infection among cord blood allogeneic transplantation recipients: low incidence of cytomegalovirus events without high-dose valacyclovir prophylaxis. Biol Blood Marrow Transplant. 2018;24:2164\u20135.","journal-title":"Biol Blood Marrow Transplant"},{"key":"730_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11899-014-0245-y","volume":"10","author":"H Liu","year":"2015","unstructured":"Liu H, van Besien K. Alternative donor transplantation\u2014\u201cmixing and matching\u201d: the role of combined cord blood and haplo-identical donor transplantation (haplo-cord SCT) as a treatment strategy for patients lacking standard donors? Curr Hematol Malig Rep. 2015;10:1\u20137.","journal-title":"Curr Hematol Malig Rep"},{"key":"730_CR16","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.bbmt.2014.08.024","volume":"20","author":"M Kwon","year":"2014","unstructured":"Kwon M, Bautista G, Balsalobre P, Sanchez-Ortega I, Serrano D, Anguita J, et al. Haplo-cord transplantation using CD34+ cells from a third-party donor to speed engraftment in high-risk patients with hematologic disorders. Biol Blood Marrow Transplant. 2014;20:2015\u201322.","journal-title":"Biol Blood Marrow Transplant"},{"key":"730_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/cid\/ciw668","volume":"64","author":"P Ljungman","year":"2017","unstructured":"Ljungman P, Boeckh M, Hirsch HH, Josephson F, Lundgren J, Nichols G, et al. Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials. Clin Infect Dis. 2017;64:87\u201391.","journal-title":"Clin Infect Dis"},{"key":"730_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jcv.2013.01.016","volume":"57","author":"JL Kroll","year":"2013","unstructured":"Kroll JL, Beam C, Li S, Viscidi R, Dighero B, Cho A, et al. Reactivation of latent viruses in individuals receiving rituximab for new onset type 1 diabetes. J Clin Virol. 2013;57:115\u20139.","journal-title":"J Clin Virol"},{"key":"730_CR19","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.3109\/10428194.2012.739688","volume":"54","author":"N Jain","year":"2013","unstructured":"Jain N, Liu H, Artz AS, Anastasi J, Odenike O, Godley LA, et al. Immune reconstitution after combined haploidentical and umbilical cord blood transplant. Leuk Lymphoma. 2013;54:1242\u20139.","journal-title":"Leuk Lymphoma"},{"key":"730_CR20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.bbmt.2012.08.019","volume":"19","author":"M Kwon","year":"2013","unstructured":"Kwon M, Balsalobre P, Serrano D, Perez Corral A, Buno I, Anguita J, et al. Single cord blood combined with HLA-mismatched third party donor cells: comparable results to matched unrelated donor transplantation in high-risk patients with hematologic disorders. Biol Blood Marrow Transplant. 2013;19:143\u20139.","journal-title":"Biol Blood Marrow Transplant"},{"key":"730_CR21","doi-asserted-by":"publisher","first-page":"6438","DOI":"10.1182\/blood-2011-08-372508","volume":"118","author":"H Liu","year":"2011","unstructured":"Liu H, Rich ES, Godley L, Odenike O, Joseph L, Marino S, et al. Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions. Blood. 2011;118:6438\u201345.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0730-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0730-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0730-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:16:11Z","timestamp":1684617371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-019-0730-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,29]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["730"],"URL":"https:\/\/doi.org\/10.1038\/s41409-019-0730-y","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,29]]},"assertion":[{"value":"9 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}